ID: MRFR/LS/4734-CR | July 2019 | Region: Global | 157 pages
According to MRFR, the Global Cell Isolation Market is poised to mature at a CAGR of 17.1% and acquire a value of USD 10.56 Billion during the review period of 2018 to 2023. The need for cell isolation is expected to rise with the rising prevalence of cancer and infectious diseases.
COVID-19 is an infectious disease caused by a new coronavirus that was most recently discovered. COVID-19 moved from a localised crisis to a global pandemic in only a few weeks, mostly unknown until the outbreak began in Wuhan (China) in December 2019. Although the COVID-19 pandemic tends to transform the development of multiple sectors, the immediate effect of the epidemic varies. While a decline in demand has been reported by a few sectors, many others will continue to remain unscathed and display exciting prospects for growth.
Growing cancer prevalence, the government support for cell-based research, and technical advances are key factors for the development of the demand for cell isolation. Market development is driven by the increasing number of cancer and infectious disease patients, expanded federal support for cell-based research, a growing emphasis on precision medicine, and developments in technology. Another big factor driving the growth of the market is the growing need for customised medicine. Personalized care is a form of psychiatric therapy in which a particular patient is tailored for the procedure. In personalised medicine, cell separation methods may be used for early diagnosis of illness, allocation of suitable medication and assessment of therapeutic prognosis.
Increasing R&D Activities In The Pharmaceutical Sector Creates Growth Avenues for Key Players
To explain their biology and create novel cell therapies and other cell-based approaches, researchers use isolated cells. Due to its significance, numerous government bodies around the globe have expanded their funding for the growth of such research activities. In the past two years, support has risen dramatically for the development of cell therapies. In exchange, this increases the market for supplies, media, reagents, and accessories used in research into cell isolation. The use of many advanced equipment and methodologies is projected to grow in developing economies with the goal of rising competitiveness due to the increasing R&D activities in the pharmaceutical and biotechnology industries.
High Cost Of Cell Isolation Systems To Impede Market Growth
On the other hand, during the projected timeframe, the high cost of cell isolation systems, complex cell behavioural features, and ethical concerns related to embryonic stem cell isolation are likely to hamper market development. The cost of study in cell biology is high because of the need to uphold high quality standards and comply with the requirements set out by regulatory authorities. Furthermore, the cell-based research success rate is very limited, and most cell therapy trials have a low success rate. Owing to financial limitations, it is impossible for numerous organisations and small-scale enterprises to buy luxury goods. As a consequence, in these countries, the use of automated kits and instruments is limited. This is one of the key reasons limiting the development of the market for cell isolation equipment.
Global Cell Isolation Market is segmented on the basis of Product, Cell Type, Technique, Application, End-User, and Region.
With a market valuation of USD 2343.3 million in 2017, consumables account for the largest share of the overall market and are forecast to reach a CAGR of 17.5 percent over the evaluation period.
By Cell Type
Owing to the rising cancer incidence that has prompted a heavy emphasis on cancer research and human stem cell therapy, the human cell type segment has the largest share of the overall market. At a CAGR of 17.4 percent during the forecast period, the human cell type segment is expected to show good growth.
At present, owing to the widespread use of this technique in university and research labs, the largest section is centrifugation-based cell isolation. Its widespread use, as opposed to other segments, is due to its affordability. Over the analysis period, centrifugation-based cell isolation is predicted to display a CAGR of 17.3 percent.
Due to the growing interest in biologics, investment in biotechnology, the prevalence of chronic diseases and the increasing need for highly efficient therapeutic solutions that stand up to the resistance of drug molecules, the biomolecules isolation segment accounts for the most important share of the overall market. In the meantime, the cancer research segment is increasingly rising and a CAGR of 17.6 percent is projected to be achieved during the forecast period due to the increasing recognition of cancer and the participation of different government health agencies in the funding of cancer research.
Owing to the usage of cell-based assays in the diagnosis of different diseases, the growing emphasis on biotechnology in the face of increasing cancer incidences and the increasing market for monoclonal antibodies & FABs as cancer therapies, biotechnology and biopharmaceutical companies are expected to report a CAGR of 17.7 percent during the study period.
The geographical overview of the global market has been conducted in four major regions, including the Asia Pacific, North America, Europe, and the rest of the world.
North America to Witness the Highest Growth
The Americas is expected to dominate the cell isolation market. The increase in the patient pool for chronic diseases, government funding for cancer research and presence of strong market players like Thermo Fisher Scientific drive the market growth in this regionThe regional market is driven by the growing need for viable care alternatives. In addition, the country is technologically innovative and there are substantially developed healthcare industries in emerging countries in the region that are at the forefront of cutting-edge science and technology. Driven by the U.S., America currently accounts for the highest share of the overall market.
Growing Presence of Major Players to Lead APAC Market
Meanwhile, during the evaluation period, Asia Pacific is forecast to rise at a robust CAGR of 17.7 percent. Asia Pacific is projected to see rapid growth in the demand for cell isolation due to rising cancer incidence and increased spending on health. Compared to other countries, the emergence of a wide demographic with a substantial customer base and the current reforms launched by the government in an attempt to change the healthcare system are projected to drive the industry..
December 2020: Applied Cells, Inc. today revealed that the organisation has launched its Early Access Program MARS Bar System, a groundbreaking fully integrated high-capacity closed system for cell processing.
By Cell Type
Frequently Asked Questions (FAQ) :
The cell isolation market valuation would be USD 10,567.4 million by 2023.
The projected CAGR would be 17.1% for the forecast period.
The end users are biotechnology & biopharmaceutical companies, cell banks, research laboratories & institutes, and hospitals & diagnostic laboratories.
The applications involved in the market are cancer research, biomolecule isolation, tissue regeneration, in-vitro diagnostics, stem cell research, and therapeutics.
The cell isolation market includes human and animal cells.
The global cell isolation market is expected to experience a CAGR of 17.1% during the forecast period of 2018 to 2023. Cell isolation has grown considerably since its emergence and demand for it is increasing due to various factors including the growing demand for personalized medicine, increasing prevalence of chronic diseases and the increasing focus on technological advancements in cell isolation devices. Valued at USD 4,098.5 Mn in 2017, the global market is expected to reach an estimated USD 10,567.4 Mn by the end of 2023.
Cell isolation is a cost-effective method which is used for the isolation of cancer cells from biopsy samples. Once isolated by the relevant instruments, the cancer cells can be used for numerous applications including biomarker identification, microarray hybridization, and genetic analysis. The growing occurrences of cancer and infectious diseases are expected to increase the demand for cell isolation. For instance, in 2014, the Centers for Disease Control and Prevention recorded 9,421 new cases of tuberculosis that were registered in the US. Moreover, according to the National Cancer Institute, in 2016, around 1,685,210 new cases of cancer were diagnosed in the US. The rising occurrence of these diseases has further prompted government health authorities and major market players to increase investment in cell isolation to meet the growing demand for cell isolation instruments.
Although cell isolation is a cost-effective process, the instruments used are highly expensive. For instance, as of 2016, the chromium Single Cell Isolation system co-developed by Bio-Rad Laboratories and Illumina costs 50,000 USD. These associated costs act as market restraints. However, the increasing interest and investment in biotechnology are expected to develop affordable instruments in the coming years. Additionally, Cell isolation is finding a novel application in microfluidics where it is used for the development of drug assays. This application is yet to be explored to its full potential, thus leading the market toward expansion in the foreseeable future.
The global cell isolation market is segmented on the basis of product, cell type, technique, application, end-user, and region. By product, the market is segmented into consumables and instruments. Consumables account for the largest share of the total market with a market value of USD 2343.3 million in 2017 and are expected to achieve a CAGR of 17.5% during the assessment period.
By cell type, the market is segmented into human cells and animal cells. The human cell type segment has the largest share of the total market due to the increasing prevalence of cancer which has driven a strong focus on cancer research and human stem cell therapy. The human cell type segment is expected to exhibit sturdy growth at a CAGR of 17.4% during the forecast period.
By technique, the market is segmented into centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation. At present, the largest segment is centrifugation-based cell isolation due to the extensive use of this technique in academic and research laboratories. Its common use is owing to its affordability as compared to other segments. Centrifugation-based cell isolation is expected to witness a CAGR of 17.3% during the review period.
By application, the market is segmented into biomolecule isolation, cancer research, stem cell research, tissue regeneration, in-vitro diagnostics, and therapeutics. The biomolecules isolation segment accounts for the most significant share of the total market due to the increasing interest in biologics, investment in biotechnology, the prevalence of chronic diseases and the increasing demand for highly effective treatment options that stand up to the resistance of drug molecules. Meanwhile, the cancer research segment is growing rapidly and is expected to achieve a CAGR of 17.6% during the forecast period due to the increasing awareness surrounding cancer and the involvement of various government health authorities for the funding of cancer research.
By end-user, the market is segmented into research laboratories & institutes, biotechnology & biopharmaceutical companies, cell banks, and hospitals & diagnostic laboratories. Biotechnology and biopharmaceutical companies are expected to register a CAGR of 17.7% through the study period due to the use of cell-based assays in the diagnosis of various diseases, the increasing focus on biotechnology in the face of increasing incidences of cancer and the increasing demand for monoclonal antibodies & FABs as cancer therapeutics.
Led by the U.S, the Americas account for the largest share of the total market at present. The increasing prevalence of chronic diseases, rising expenses in R&D activities conducted by healthcare organizations and government bodies and the increasing demand for appropriate treatment options are driving the regional market. Moreover, the region is technologically advanced and developing countries in the region possess significantly developed healthcare sectors which are at the forefront of cutting-edge research and technology.
Meanwhile, the Asia Pacific is expected to grow at a robust CAGR of 17.7% during the assessment period. The presence of a massive population with a significant patient pool as compared to other regions and the ongoing initiatives introduced by the government in an effort to reform the healthcare sector is expected to drive the market. Countries such as Singapore, Australia, Malaysia, China, and India are the most lucrative markets in the region and have large patient pools, high amount of geriatric population and rapidly improving healthcare facilities. The market is restrained by the lack of appropriate capital, among other factors. However, a supportive regulatory framework regarding research of biotechnology is expected to boost market growth.
Prominent players participating in the global cell isolation market include GE Healthcare, Becton, Dickinson & Company, Beckman Coulter, Thermo Fisher Scientific Inc., and Merck KGaA. Other players of note include TERUMO Corporation, Bio-Rad Laboratories, Miltenyi Biotec, STEMCELL Technologies, F.Hoffman-La Roche AG, and others. Research and Development are the key market strategies utilized by these players to compel further growth for the market.
Global Cell Isolation Market: Competitive Landscape
The global cell isolation market is a huge market with a number of big market players operating in various regions across the world. These players have come up with innovative products that are being used for various applications such as cancer research, stem cell research, and many others. Some of the major players include Thermo Fisher Scientific Inc., GE Healthcare, Becton, Dickinson and Company, Beckman Coulter, Merck KGaA, STEMCELL Technologies, Miltenyi Biotec, TERUMO CORPORATION, Bio-Rad Laboratories Inc, and F. Hoffmann-La Roche AG. Apart from these, there is a large number of companies involved in the development of new products.
The global cell isolation market is currently dominated by Thermo Fisher Scientific Inc. with 11.8% of the total market share. Thermo Fisher Scientific with its technically magnificent products and skilled workforce is assisting its customers to accelerate life science research as well as to get better outcomes in challenging clinical research fields. Through their premier brands Thermo Scientific, Invitrogen, Fisher Scientific Applied Biosystems, and Unity Lab Services cater to several products such as analytical instruments, laboratory supply chain programs and e-commerce, laboratory equipment, lab services, specialty diagnostics, and others.
GE Healthcare has the second largest market share in the global cell isolation market. GE Healthcare held 10.5% of the total market in 2017. The company was founded in 2004. GE Healthcare is a unit of General Electric Company.GE healthcare is expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement, and performance solutions. It helps its customers to deliver better care and facilities around the world at low cost.
It collaborates with human services pioneers, endeavoring to influence the worldwide arrangement change that is important to actualize an effective move toward practical medicinal service frameworks.
GE Healthcare has generated massive revenues from the sales of healthcare. Besides these two, Becton, Dickinson and Company, Beckman Coulter, and Merck KGaA have secured third, fourth, and fifth positions with 9.6%, 7.9%, and 6.2% respectively of the market share.